at Nasdaq.com (Fri, 12:21PM)
Acadia Pharmaceuticals (ACAD +10.6%) jumps after announcing an $86.4M private placement. The...
Acadia Pharmaceuticals (ACAD +10.6%) jumps after announcing an $86.4M private placement. The securities are to be sold at $4.43 per share, and will be used primarily to support completion of it's Phase III pimavanserin program, including a planned confirmatory Phase III pivotal trial in Parkinson's disease psychosis.
From other sites
at Benzinga.com (Jan 12, 2015)
at CNBC.com (Dec 12, 2014)
at Nasdaq.com (Nov 17, 2014)
at CNBC.com (Nov 4, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs